IRIDEX Corporation (IRIX) earnings
IRIX earnings moved a median of -0.17% by the close. Quarterly and annual IRIX reports and results, each read against the price at its own news timestamp. Back to the IRIX overview →
31 measured IRIX earnings events.
Where these IRIX earnings landedvs 30 measured IRIX earnings reactions
| Middle 50% of IRIX earnings reactions | -4.16% to +2.34% |
|---|---|
| Median reaction (to close) | -0.17% |
| Measured reactions | 30 |
Point-in-time · zero look-ahead
Half of the 30 IRIX earnings events with a measured close landed between -4.16% and +2.34%; 43% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q IRIDEX CORP For: Jul 04 | SEC filing · Form 10-Q | -5.76% | -4.17% | |
| Iridex Reports Second Quarter 2026 Financial Results | Press release | -5.76% | -4.17% | |
| Iridex to Report Second Quarter 2026 Financial Results on August 18, 2026 | Press release | — | +0.97% | |
| Form 10-Q IRIDEX CORP For: Apr 04 | SEC filing · Form 10-Q | +1.50% | +0.00% | |
| Iridex Reports First Quarter 2026 Financial Results | Press release | +1.50% | +0.00% | |
| Iridex to Report First Quarter 2026 Financial Results on May 19, 2026 | Press release | -0.94% | -0.95% | |
| Form 10-K IRIDEX CORP For: Jan 03 | SEC filing · Form 10-K | +3.06% | +1.69% | |
| Form 10-Q IRIDEX CORP For: Sep 27 | SEC filing · Form 10-Q | -0.47% | — | |
| Iridex Reports Third Quarter 2025 Financial Results | Press release | -5.46% | -8.26% | |
| Iridex to Report Third Quarter 2025 Financial Results on November 11, 2025 | Press release | +2.94% | +0.98% | |
| Form 10-Q IRIDEX CORP For: Jun 28 | SEC filing · Form 10-Q | +0.00% | -10.61% | |
| Iridex Reports Second Quarter 2025 Financial Results | Press release | +0.00% | -10.61% | |
| Iridex to Report Second Quarter 2025 Financial Results on August 12, 2025 | Press release | +0.00% | -0.71% | |
| Form 10-Q IRIDEX CORP For: Mar 29 | SEC filing · Form 10-Q | +0.00% | -9.09% | |
| Iridex Reports First Quarter 2025 Financial Results | Press release | +0.00% | -9.09% | |
| Iridex to Report First Quarter 2025 Financial Results on May 13, 2025 | Press release | +0.00% | -2.48% | |
| Iridex Announces Preliminary Operational and Financial Results for the First Quarter 2025 | Press release | +3.09% | +3.09% | |
| Form 10-K IRIDEX CORP For: Dec 28 | SEC filing · Form 10-K | -6.59% | -5.75% | |
| Form 10-Q IRIDEX CORP For: Sep 28 | SEC filing · Form 10-Q | +7.74% | +21.93% | |
| Iridex Reports Third Quarter 2024 Financial Results | Press release | +7.74% | +21.93% | |
| Iridex to Report Third Quarter 2024 Financial Results on November 12, 2024 | Press release | -2.82% | -1.41% | |
| Form 10-Q IRIDEX CORP For: Jun 29 | SEC filing · Form 10-Q | — | -4.12% | |
| Iridex Reports Second Quarter 2024 Financial Results | Press release | — | -4.12% | |
| Iridex to Report Second Quarter 2024 Financial Results on August 8, 2024 | Press release | — | +2.55% | |
| Form 10-Q IRIDEX CORP For: Mar 30 | SEC filing · Form 10-Q | +1.97% | +4.33% | |
| Iridex Reports First Quarter 2024 Financial Results | Press release | +1.97% | +4.33% | |
| Iridex to Report First Quarter 2024 Financial Results on May 14, 2024 | Press release | +1.77% | +0.71% | |
| Form 10-K IRIDEX CORP For: Dec 30 | SEC filing · Form 10-K | -1.67% | -0.33% | |
| Form 10-Q IRIDEX CORP For: Sep 30 | SEC filing · Form 10-Q | +0.00% | +0.49% | |
| Form NT 10-Q IRIDEX CORP For: Sep 30 | SEC filing · Form NT | +3.08% | +4.10% | |
| Iridex Reports Third Quarter 2023 Financial Results and Business Update | Press release | +3.08% | +4.10% |
Keep exploring
More IRIX: analyst actions → · SEC filings → · IRIX overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Array Technologies, Inc. (ARRY) | 249 | -0.24% | 41% |
| Cytosorbents Corporation (CTSO) | 249 | 0.00% | 49% |
| Kala Pharmaceuticals, Inc. (KALA) | 248 | +0.41% | 56% |
| MELINTA THERAPEUTICS INC (MLNT) | 248 | -0.38% | 34% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.